Startup profile

Pumpkinseed

Series APalo Alto, California, United States$20M raised

Open roles0
Total raised$20M
Team size11-50
Founded · Stage2021 · Series A

We pull jobs from sources most job seekers never check

Email icon

Get Real-Time Job Alerts For Free

Jobs updated every minute. Get notified for free when new roles matching your interests go live.

No categories available

About the company

What they build and who they serve.

Pumpkinseed is a Palo Alto-based protein sequencing company developing deSIPHR, a nanophotonic chip platform that reads proteins de novo from molecular vibrations using high-throughput Raman spectroscopy. With over 100 million sensors per square centimeter fabricated via standard semiconductor processes, the platform identifies known and unknown proteins at single-molecule resolution — including post-translational modifications and non-canonical residues that mass-spectrometry tools miss. The company sells proteomic data to biopharma and biosecurity partners and is generating the high-resolution datasets that virtual cell models and AI-driven drug discovery require.

Team & contacts

Key people at the company—reach out on LinkedIn or email.

Why it matters

Signals from funding, traction, and product direction.

  • Co-led by NfX (Omri Amirav-Drory) and Future Ventures (Steve Jurvetson, Maryanna Saenko); participation from Base4 Capital, ADVentures (Analog Devices CVC), and Stanford.
  • Pumpkinseed has secured over $12M in committed near-term revenue through active contracts with Genentech, DARPA, and BARDA across immunology, precision medicine, and biothreat detection.
  • Proprietary deSIPHR (de novo Sequencing and Identification of Proteins with High-throughput Raman) nanophotonic chip carries 100M sensors per square centimeter and amplifies Raman scattering over 10 million-fold for single-molecule reads.
  • The company plans a $30-40M Series B within the next year per executive chairwoman Jen Dionne (Axios Pro). Co-founders: Stanford professor Jennifer Dionne, Dr. Jack Hu, and Dr. Nhat Vu.

Funding history

Rounds and investors over time, newest first.

  1. Series A

    $20M
    NFX · LeadFuture Ventures · LeadADVentures (Analog Devices, Inc.)Stanford UniversityBase4 Capital

In the news

Press, announcements, and coverage about this company.

Investors

NFXFuture VenturesADVentures (Analog Devices, Inc.)Stanford UniversityBase4 Capital

Focus areas

Series ADeep TechBiotechnologyHealthtech
Email alerts

Don’t get beat to tomorrow’s openings

New roles go live every minute and the earliest applicants win. Get the freshest, verified listings delivered straight to your inbox before most job seekers ever see them.

👉 Get free daily job posts